The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis

Luca Mastrantoni; Armando Orlandi; Antonella Palazzo; Giovanna Garufi; Alessandra Fabi; Gennaro Daniele; Diana Giannarelli; Giampaolo Tortora; Emilio Bria

doi:10.1016/j.eclinm.2023.101824

The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis

Luca Mastrantoni, Armando Orlandi, Antonella Palazzo, Giovanna Garufi, Alessandra Fabi, Gennaro Daniele, Diana Giannarelli, Giampaolo Tortora, Emilio Bria

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	101824-N/A
Rivista	EClinicalMedicine
Volume	56
DOI	https://doi.org/10.1016/j.eclinm.2023.101824
Stato di pubblicazione	Pubblicato - 2023

Keywords

CDK4/6 inhibitors
LHH
Metastatic breast cancer
NNH
NNT

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/j.eclinm.2023.101824

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

Mastrantoni, L., Orlandi, A., Palazzo, A., Garufi, G., Fabi, A., Daniele, G., Giannarelli, D., Tortora, G., & Bria, E. (2023). The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis. EClinicalMedicine, 56, 101824-N/A. https://doi.org/10.1016/j.eclinm.2023.101824

@article{1125fd46805b4ffbb986df873e4f8cb9,

title = "The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis",

keywords = "CDK4/6 inhibitors, LHH, Metastatic breast cancer, NNH, NNT, CDK4/6 inhibitors, LHH, Metastatic breast cancer, NNH, NNT",

author = "Luca Mastrantoni and Armando Orlandi and Antonella Palazzo and Giovanna Garufi and Alessandra Fabi and Gennaro Daniele and Diana Giannarelli and Giampaolo Tortora and Emilio Bria",

year = "2023",

doi = "10.1016/j.eclinm.2023.101824",

language = "English",

volume = "56",

pages = "101824--N/A",

journal = "EClinicalMedicine",

issn = "2589-5370",

publisher = "Elsevier Ltd",

}

Mastrantoni, L, Orlandi, A, Palazzo, A, Garufi, G, Fabi, A, Daniele, G, Giannarelli, D, Tortora, G & Bria, E 2023, 'The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis', EClinicalMedicine, vol. 56, pagg. 101824-N/A. https://doi.org/10.1016/j.eclinm.2023.101824

The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis. / Mastrantoni, Luca; Orlandi, Armando; Palazzo, Antonella et al.
In: EClinicalMedicine, Vol. 56, 2023, pag. 101824-N/A.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis

AU - Mastrantoni, Luca

AU - Orlandi, Armando

AU - Palazzo, Antonella

AU - Garufi, Giovanna

AU - Fabi, Alessandra

AU - Daniele, Gennaro

AU - Giannarelli, Diana

AU - Tortora, Giampaolo

AU - Bria, Emilio

PY - 2023

Y1 - 2023

KW - CDK4/6 inhibitors

KW - LHH

KW - Metastatic breast cancer

KW - NNH

KW - NNT

KW - CDK4/6 inhibitors

KW - LHH

KW - Metastatic breast cancer

KW - NNH

KW - NNT

UR - http://hdl.handle.net/10807/231574

U2 - 10.1016/j.eclinm.2023.101824

DO - 10.1016/j.eclinm.2023.101824

M3 - Article

SN - 2589-5370

VL - 56

SP - 101824-N/A

JO - EClinicalMedicine

JF - EClinicalMedicine

ER -